[
    [
        {
            "time": "",
            "original_text": "迈瑞医疗：公司专注于医疗器械领域，在中医药领域无相关研发投入",
            "features": {
                "keywords": [
                    "迈瑞医疗",
                    "医疗器械",
                    "中医药",
                    "研发投入"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "迈瑞医疗：公司专注于医疗器械领域，在中医药领域无相关研发投入",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "迈瑞医疗：公司在韩国市场的收入占总收入的比例较低，占有率还有很大的提升空间",
            "features": {
                "keywords": [
                    "迈瑞医疗",
                    "韩国市场",
                    "收入比例",
                    "提升空间"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "迈瑞医疗：公司在韩国市场的收入占总收入的比例较低，占有率还有很大的提升空间",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "紫金矿业50亿进军锂业，宁德时代却成最大赢家！",
            "features": {
                "keywords": [
                    "紫金矿业",
                    "锂业",
                    "宁德时代",
                    "投资"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "矿业",
                    "新能源"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "紫金矿业50亿进军锂业，宁德时代却成最大赢家！",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业2021年10月投资策略：关注三季报增长与估值切换",
            "features": {
                "keywords": [
                    "医药生物",
                    "投资策略",
                    "三季报",
                    "估值切换"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业2021年10月投资策略：关注三季报增长与估值切换",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "医药行业周报：默沙东新冠药数据公布 腾盛博药递交FDA+EUA申请",
            "features": {
                "keywords": [
                    "医药行业",
                    "默沙东",
                    "新冠药",
                    "FDA",
                    "EUA"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业周报：默沙东新冠药数据公布 腾盛博药递交FDA+EUA申请",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "国家财政部：137种医疗器械100%采购国产 前BMS全球高管任恒瑞副总裁【最新闻1011】",
            "features": {
                "keywords": [
                    "财政部",
                    "医疗器械",
                    "国产化",
                    "恒瑞医药"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国家财政部：137种医疗器械100%采购国产 前BMS全球高管任恒瑞副总裁【最新闻1011】",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "A股午盘综述：煤炭、军工、银行、保险造好，中国神华、招商银行大涨",
            "features": {
                "keywords": [
                    "A股",
                    "煤炭",
                    "军工",
                    "银行",
                    "保险"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "煤炭",
                    "军工",
                    "银行",
                    "保险"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股午盘综述：煤炭、军工、银行、保险造好，中国神华、招商银行大涨",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "创业板指跌超1%，迈瑞医疗均跌近4%",
            "features": {
                "keywords": [
                    "创业板指",
                    "迈瑞医疗",
                    "下跌"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "创业板指跌超1%，迈瑞医疗均跌近4%",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "A股10月解禁市值超4800亿元 迈瑞医疗规模居首 解禁",
            "features": {
                "keywords": [
                    "A股",
                    "解禁",
                    "迈瑞医疗"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "A股10月解禁市值超4800亿元 迈瑞医疗规模居首 解禁",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "前三季度机构调研热情高涨，迈瑞医疗被“翻牌”最多",
            "features": {
                "keywords": [
                    "机构调研",
                    "迈瑞医疗",
                    "热情高涨"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "前三季度机构调研热情高涨，迈瑞医疗被“翻牌”最多",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药行业周报：本周医药板块上涨0.27 建议关注双限政策及新冠药物板块",
            "features": {
                "keywords": [
                    "医药行业",
                    "双限政策",
                    "新冠药物",
                    "上涨"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业周报：本周医药板块上涨0.27 建议关注双限政策及新冠药物板块",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]